Akèy › Limfom selil mantèl › Kalifòni › Baldwin Park
Etid klinik pou Limfom selil mantèl nan Baldwin Park, CA
15 etid pou Limfom selil mantèl ap chèche patisipan nan sit nan ak bò kote Baldwin Park (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
Ap rekriteFaz 2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi lwen
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Ap rekriteFaz 1/2
- City of Hope, Duarte · 4 mi lwen
Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
Ap rekriteFaz 1/2
- City of Hope Medical center, Duarte · 4 mi lwen
Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Ap rekriteFaz 1/2
- City of Hope, Duarte · 4 mi lwen
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma
Ap rekriteFaz 2
- City of Hope Medical Center, Duarte · 4 mi lwen
Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Ap rekriteFaz 2
- City of Hope Medical Center, Duarte · 4 mi lwen
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Duarte · 4 mi lwen
Etid Limfom selil mantèl nan lòt vil
- Houston, TX15 etid
- Durham, NC13 etid
- New York City, NY12 etid
- Milwaukee, WI12 etid
- Seattle, WA12 etid
- Boston, MA11 etid
- Columbus, OH11 etid
- Nashville, TN11 etid
- Chicago, IL10 etid
- Portland, OR9 etid
- Rochester, MN9 etid
- St. Louis, MO8 etid
Lòt etid nan Baldwin Park
- Kansè nan tete45 etid
- Leksemi mieloïd egi40 etid
- Kansè kolorektal38 etid
- Kansè Poumon ki pa ti selil36 etid
- Kansè (tout kalite)33 etid
- Kansè pwostat30 etid
- Kansè Metastatik30 etid
- Sendwòm myelodisplastik26 etid
- Kansè ovè25 etid
- Kansè poumon24 etid
- Myelom Miltip23 etid
- Kansè lestomak22 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.